Abstract
The hematopoietic system is organized as a hierarchy where the majority of the cells are mature, and therefore, need to be continuously replenished from a small pool of immature progenitors. Ultimately, the entire hematopoietic system is derived from stem cells that have extensive proliferative and differentiation capacity and give rise to all myeloid and lymphoid lineages. Insight into the biology of these stem cells is, therefore, fundamental to our understanding of the regulation of normal and abnormal hematopoiesis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Metcalf D. Haemopoietic colonies: In vitro cloning of normal and leukemic cells. Recent Results in Cancer Res 1977; 61: 1–227.
Fauser A, Messner H. Granuloerythropoietic colonies in human marrow, peripheral blood and cord blood. Blood 1978; 52: 1243–48.
Leary A, Ogawa M. Blast colony assay for umbilical blood and adult bone marrow progenitors. Blood 1987; 69: 953–56.
Dexter TM, Moore MAS, Sheridan APC. Maintenance of hematopoietic stem cells and production of differentiated progeny in allogeneic and semiallogenic bone marrow chimeras in vitro. J Exp Med 1977; 145: 1612–16.
Fraser CC, Szilvassy SJ, Eaves CJ et al. Proliferation of totipotent hematopoietic stem cells in vitro with retention of long-term competitive in vivo reconstituting ability. Proc Natl Acad Sci USA 1992; 89: 1968–72.
van der Sluijs JP, van den Bos C, Baert MRM et al. Loss of long-term repopulating ability in long-term bone marrow culture. Leukemia 1993; 7: 725–32.
Phillips RA. Hematopoietic stem cells: concepts, assays, and controversies. Sem Immunol 1991; 3: 337–47.
Till JE, McCulloch EA. Hemopoietic stem cell differentiation. Biochim Biophys Acta 1980; 605: 431–59.
Till JE, McCulloch EA. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res 1961; 14: 213–22.
Paige CJ, Kincade PW, Shinefeld LA et al. Precursors of murine B lymphocytes: Physical and functional characterization, and distinctions from myeloid stem cells. J Exp Med 1981; 153: 154–65.
Lemischka IR. Clonal, in vivo behavior of the totipotent hematopoietic stem cell. Sem Immunol 1991; 3: 349–55.
Abramson S, Miller RG, Phillips RA. The identification in adult bone marrow of pluripotent and restricted stem cells of the myeloid and lymphoid systems. J Exp Med 1977; 145: 1567–79.
Dick JE, Magli MC, Huszar D et al. Introduction of a selectable gene into primitive stem cells capable of long-term reconstitution of the hemopoietic system of W/LW mice. Cell 1985; 42: 71–9.
Keller G, Paige C, Gilboa E et al. Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent hemopoietic precursors. Nature 1985; 318: 149–54.
Lemischka IR, Raulet DH, and Mulligan RC. Developmental potential and dynamic behavior of hematopoietic stem cells. Cell 1986; 45: 917–27.
Mosier D, Gulizia R, Baird S et al. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988; 335: 256–59.
Lubin I, Faktorowich Y, Lapidot T et al. Engraftment and development of human T and B cells in mice after bone marrow transplantation. Science 1991; 252: 345–76.
McCune J, Namikawa R, Kaneshima H et al. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 1988; 241: 1632–39.
Kamel-Reid S, Dick JE. Engraftment of immune-deficient mice with human hematopoietic stem cells. Science 1988; 242: 1706–09.
Kaneshima H, Namikawa R, McCune JM. Human hematolymphoid cells in SCID mice. Curr Opin Immunol 1994; 6: 327–33.
Sutherland H, Eaves C, Lansdorp P et al. Differential regulation of primitive human hematopoietic cells in long-term cultures maintained on ge-
netically engineered murine stromal cells. Blood 1991; 78: 666–72.
Andriole G, Mule J, Hansen C et al. Evidence that lymphokine-activated killer cells and natural killer cells are distinct based on an analysis of congenitally immunodeficient mice. J Immunol 1985; 135: 2911–13.
Rawlins DJ, Saffran DC, Tsukada S et al. Mutation of unique region of Bruton’s tyrosine kinase in immunodeficient XID mice. Science 1993; 261: 358–61.
Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature 1983; 301: 527–30.
Fulop G, Phillips R. The scid mutation in mice causes a general defect in radiation repair. Nature 1990; 347: 479–82.
Lapidot T, Pflumio F, Doedens M et al. Cytokine stimulation of multilineage human hematopoiesis from immature cells transplanted into scid mice. Science 1992; 255: 1137–41.
Broxmeyer HE, Kurtzberg J, Gluckman E et al. Umbilical cord blood hematopoietic stem and repopulating cells in human clinical transplantation. Blood Cells 1991; 17: 313–29.
Broxmeyer HE, Douglas GW, Hangoc G et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Nati Acad Sci USA 1989; 86: 3828–32.
Broxmeyer HE, Hangoc G, Cooper S et al. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci USA 1992; 89: 4109–13.
Carow CE, Hangoc G, Broxmeyer HE. Human multipotential progenitor cells (CFU-GEMM) have extensive replating capacity for secondary CFUGEMM: an effect enhanced by cord blood plasma. Blood 1993; 81: 942–49.
Lansdorp PM, Dragowska W, Mayani H. Ontogeny-related changes in proliferative potential of human hematopoietic cells. J Exp Med 1993; 178: 787–91.
Hows JM, Bradley BA, Marsh JC et al. Growth of human umbilical-cord blood in long-term hemopoietic cultures. Lancet 1992; 340: 73–6.
Vormoor J, Lapidot T, Pflumio F et al. Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice. Blood 1994; 83: 2489–97.
Civin CI, Trischmann TM, Fackler MJ et al. Report on the CD34 cluster workshop. In: Knapp W, Dorken B, Gilks WR et al, eds. Leukocyte Typing IV: White Cell Differentiation Antigens. Oxford: Oxford University Press, 1990: 818.
Craig W, Kay R, Cutler RL et al. Expression of Thy-1 on human hematopoietic progenitor cells. J Exp Med 1993; 177: 1331–42.
Baum CM, Weissman IL, Tsukamoto AS et al. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA 1992; 89: 2804–08.
Shultz L, Schweitzer P, Christianson S, Gott B, et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 1995; 154: 180–191.
Lim B, Apperley JF, Orkin SH et al. Long-term expression of human adenosine deaminase in mice transplanted with retrovirus-infected hematopoietic stem cells. Proc Natl Acad Sci USA 1989; 86: 8892–96.
Bodine DM, Karlsson S, Nienhuis AW. Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirusmediated gene transfer into hematopoietic stem cells. Proc Natl Acad Sci USA 1989; 86: 8897–8901.
Carter R, Abrams-Ogg A, Dick J et al. Autologous transplantation of canine long-term marrow culture cells genetically marked by retroviral vectors. Blood 1992; 79: 356–64.
van Beusechem VW, Kukler A, Heidt PJ et al. Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus-infected bone-marrow cells. Proc Natl Acad Sci USA 1992; 89: 7640–44.
Bodine DM, Moritz T, Donahue RE et al. Long-term in vivo expression of a murine adenosine deaminase gene in rhesus monkey hematopoietic cells of multiple lineages after retroviral mediated gene transfer into CD34’ bone marrow cells. Blood 1993; 82: 1975–80.
Dick J, Kamel-Reid S, Murdoch B et al. Gene transfer into normal human hematopoietic cells using in vitro and in vivo assays. Blood 1991; 78: 624–34.
Ferrari G, Rossini S, Giavazzi R et al. An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency. Science 1991; 251: 1363–66.
Nolta JA, Hanley MB, Kohn DB. Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: Analysis of gene transduction of long-lived progenitors. Blood 1994; 83: 3041–51.
Moritz T, Keller DC, Williams DA. Human cord blood cells as targets for gene transfer: Potential use in genetic therapy of severe combined immunodeficiency disease. J Exp Med 1993; 178: 529–36.
Karlsson S. Treatment of genetic defects in hematopoietic cell function by gene transfer. Blood 1991; 78: 2481–92.
Weatherall DJ, Clegg JB. The Thalassaemia Syndromes. Oxford: Blackwell Scientific Publications, 1981.
Bunn HF, Forget BG. Hemoglobin: Molecular, Genetic and Clinical Aspects. Philadelphia: Saunders, 1986.
Larochelle A, Vormoor J, Lapidot T et al. Engraftment of immune-deficient mice with primitive hematopoietic cells from (3–thalassemia and sickle cell anemia patients: implications for evaluating human gene therapy protocols. Human Molecular Genetics 1995; 4: 163–172.
Daley GQ, Van Etten RA, Baltimore D. Induction of the chronic myelogenous leukemia in mice by the p2106“i”“ gene of the Philadelphia chromosome. Science 1990; 247: 824–30.
Elefanty AG, Hariharan IK, Cory S. ber-abl, the hallmark of chronic myeloid leukemia in man, induces multiple hemopoietic neoplasms in mice. EMBO J 1990; 9: 1069–1078.
Voncken JW, Griffiths S, Greaves MF et al. Restricted oncogenicity of BCR-ABL p190 in transgenic mice. Cancer Res 1992; 52: 4534–39.
Donehower LA, Harvey M, Slagle BL et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. 1992; 356: 215–21.
Dick J. Immune-deficient mice as models of normal and leukemic human hematopoiesis. Cancer Cells 1991; 3: 39–48.
Kamel-Reid S, Letarte M, Sirard C et al. A model of human acute lymphoblastic leukemia in immune-deficient SCID mice. Science 1989; 246: 1597–1600.
Kamel-Reid S, Letarte M, Doedens M et al. Bone marrow from children in relapse with pre-B acute lymphoblastic leukemia proliferates and disseminates rapidly in scid mice. Blood 1991; 78: 2973–81.
Cesano A, O’Connor R, Lange B et al. Homing and progression patterns of childhood acute lymphoblastic leukemias in severe combined immunodeficiency mice. Blood 1991; 77: 2463–74.
Uckun FM, Downing JR, Gunther R et al. Human t(1;19)(q23;p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency. Blood 1993; 81: 3052–62.
Sawyers C, Gishizky M, Quan S et al. Propagation of human blastic myeloid leukemias in the SCID mouse. Blood 1992; 79: 2089–98.
Griffin DJ, Löwenberg B. Clonogenic cells in acute myeloblastic leukemia. Blood 1986; 68: 1185–95.
Hu JP, Cesano A, Santoli D et al. Effects of interleukin-11 on the proliferation and cell cycle status of myeloid leukemic cells. Blood 1993; 81: 1586–92.
Lapidot T, Sirard C, Vormoor J et al. A cell initiating human acute myeloid leukemia after transplantation into SCID mice. Nature 1994; 367: 645–48.
McCulloch E. Stem cells in normal and leukemic hemopoiesis (Henry Stratten Lecture). Blood 1983; 62: 1–13.
McCulloch EA, Minden MD, Miyauchi J et al. Stem cell renewal and differentiation in acute myeloblastic leukemia. J Cell Sci Suppl 1988; 10: 267–81.
Porter EH, Berry RJ. The efficient design of transplantable tumor assays. Brit J Cancer 1964; 17: 583–95.
Terstappen LWMM, Safford M, Unterhalt M et al. Flow cytometric characterization of acute myeloid leukemia: IV. Comparison to the differentiation pathway of normal hematopoietic progenitor cells. Leukemia 1992; 6: 993–1000.
Terstappen LWWM, Huang S, Safford M et al. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34’CD38– progenitor cells. Blood 1991; 77: 1218–27.
Huang S, Terstappen LWMM. Lymphoid and myeloid differentiation of single human CD34’, HLA-DR’, CD38– hematopoietic stem cells. Blood 1994; 83: 1515–1526.
Lapidot T, Cohen A, Grunberger T et al. Aberrant growth properties of juvenile chronic myelogenous leukemia (JCML) CD34’ cells in vitro and in vivo using SCID mouse assays. Blood 1993; 82 (Suppl 1): 197a.
Freedman MH, Estrov Z, Chan HSL. Juvenile chronic myelogenous leukemia. Am J Ped Hemat Oncol 1988; 10: 261–67.
Freedman MH, Cohen A, Grunberger T et al. Central role of tumor necrosis factor, GM-CSF, and interleukin 1 in the pathogenesis of juvenile chronic myelogenous leukemia. Br J Haematol 1992; 80: 40–48.
Rowley JD. The Philadelphia chromosome translocation - A paradigm for understanding leukemia (Charles S. Mott Prize). Cancer 1990; 65: 2178–84.
Witte ON. Role of the ber-abl oncogene in human leukemia: fifteenth Richard and Hinda Rosenthal foundation award lecture. Cancer Res 1993; 53: 485–89.
Jonas D, Lübbert M, Kawasaki ES et al. Clonal analysis of her-abl rearrangement in T lymphocytes from patients with chronic myelogenous leukemia. Blood 1992; 79: 1017–23.
Eaves C, Eaves A. Cell culture studies in CML. Baillere’s Clin Haematol 1987; 1: 931–61.
Dunbar CE, Stewart FM. Separating the wheat from the chaff: Selection of benign hematopoietic cells in chronic myeloid leukemia. Blood 1992; 79: 1107–10.
Udomsakdi C, Eaves CJ, Swolin B et al. Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level. Proc Natl Acad Sci USA 1992; 89: 6192–96.
Bock TA, Dunbar CE, Orlic D et al. Transgenic SCID mice containing the human IL-3, GM-CSF, and SCF genes as a model for human hematopoiesis. Blood 1993; 82 (Suppl. 1): 457a.
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Vormoor, J., Lapidot, T., Larochelle, A., Dick, J.E. (1995). Human Hematopoiesis in SCID Mice. In: Human Hematopoiesis in SCID Mice. Medical Intelligence Unit. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-22008-5_10
Download citation
DOI: https://doi.org/10.1007/978-3-662-22008-5_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-22010-8
Online ISBN: 978-3-662-22008-5
eBook Packages: Springer Book Archive